Concepedia

Melanie Nyuydzefe

MN

Statistics

Publications

9

Citations

804

H-Index

9

Active since

2014

Affiliations

Eon Corporation (United States)(Current)

QIMR Berghofer Medical Research Institute

University of Minnesota Medical Center

Masonic Cancer Center

The University of Queensland

Melanie Nyuydzefe is an author at Eon Corporation (United States) specializing in life sciences, cell signaling, and signal transduction.

Publications per year

2014–2024

9

Publications

9

Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism

Alexandra Zanin‐Zhorov, Jonathan M. Weiss, Melanie Nyuydzefe et al. · Proceedings of the National Academy of Sciences · 2014 · 253 citations · Full text

, , +17

Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism

Ryan Flynn, Katelyn Paz, Jing Du et al. · Blood · 2016 · 215 citations · Full text

, , +8

Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10

Alexandra Zanin‐Zhorov, Jonathan M. Weiss, Alissa Trzeciak et al. · The Journal of Immunology · 2017 · 94 citations · Full text

, , +17

ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis

Christina Nalkurthi, Wayne A. Schroder, Michelle Melino et al. · JHEP Reports · 2021 · 73 citations · Full text

, , +17

ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings

Jonathan M. Weiss, Wei Chen, Melanie Nyuydzefe et al. · Science Signaling · 2016 · 59 citations · Full text

, , +17

1–5 of 9